CDC Confirms Missouri H5 Bird Flu Case
avian Influenza A(H5) Case Confirmed in Missouri: A New Dimension in U.S. Surveillance
September 6, 2024 – The Centers for Disease Control and Prevention (CDC) has confirmed a human case of avian influenza A(H5), commonly known as H5 bird flu, in Missouri. This marks a significant progress, as it is the first reported human H5 case in the United States during 2024 without a known occupational exposure to sick or infected animals. The finding was made through Missouri’s routine seasonal flu surveillance system, highlighting the critical role of robust public health infrastructure in detecting novel threats.
The patient, who was hospitalized, had pre-existing medical conditions and has as recovered after receiving influenza antiviral treatment. The Missouri Department of Health and Senior Services (DHSS) is currently investigating the circumstances surrounding the potential exposure.Crucially, no ongoing transmission among close contacts or the wider community has been identified.
This case brings the total number of human H5 infections reported in the U.S. in 2024 to 14. While outbreaks of H5 have been documented in commercial and backyard poultry flocks across the nation, and H5N1 has been detected in wild birds in Missouri previously, this instance is unique due to the absence of a clear animal contact link.The detection of this case through the national flu surveillance system is a notable achievement. Previously, all other human H5 cases in the U.S. were identified through targeted surveillance efforts specifically designed to monitor H5 outbreaks in animals. In this instance, the patient’s specimen initially tested positive for influenza A but did not match known seasonal flu A virus subtypes, triggering further, more detailed testing.
The CDC continues to monitor influenza surveillance data closely, especially in states experiencing animal outbreaks. to date, ther have been no indications of unusual influenza activity in human populations, including in Missouri. Further genomic sequencing is underway to identify the specific neuraminidase subtype of the virus and to fully sequence its genome.
Based on current data, the CDC maintains its assessment that the risk to the general public from H5N1 remains low.The agency’s existing recommendations regarding H5 virus precautions have not changed. However, the CDC emphasizes that the situation is dynamic and can evolve as more facts becomes available. The findings from this ongoing inquiry, especially the lack of an apparent animal exposure, will be vital in understanding potential transmission pathways and informing future public health guidance. While rare, novel influenza A cases where an animal source cannot be identified do occur, and the primary concern in such scenarios is the absence of onward human-to-human transmission.
The confirmation of this H5 case through routine surveillance underscores the evolving landscape of influenza monitoring. As we continue to navigate the complexities of avian influenza, the ability to detect and respond to novel strains, even in the absence of direct animal contact, will be paramount in safeguarding public health. This development reinforces the need for sustained investment in surveillance systems and a proactive approach to understanding and mitigating the risks posed by emerging infectious diseases.